Open an Account
search icon
4
NOTIFICATIONS
Best Algo trading app in India
Bigul

Indo Us Bio-Tech Ltd - 541304 - Board Meeting Intimation for Appointment Of Ms. Dimpy Joshi, A Qualified Company Secretary And Holding Associate Membership Of Institute Of Company Secretaries Of India As A Company Secretary And Compliance Officer Of The Company.

 Indo Us Bio-Tech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 24/01/2020 ,inter alia, to consider and approve appointment of Ms. Dimpy Joshi, a qualified Company Secretary and holding Associate Membership of Institute of Company Secretaries of India, as a Company Secretary and Compliance Officer of the Company.
21-01-2020
Bigul

Indo Us Bio-Tech Ltd - 541304 - Shareholding for the Period Ended December 31, 2019

 Indo Us Bio-Tech Ltd has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2019. For more details, kindly Click here
13-01-2020
Bigul

Indo Us Bio-Tech Ltd - 541304 - Statement Of Investor Complaints For The Quarter Ended December 2019

 No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- JAGDISH AJUDIADesignation :- Director
10-01-2020
Bigul

Indo Us Bio-Tech Ltd - 541304 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

 We herewith enclose a Certificate dated 04th January, 2020 under Regulation 74 (5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended 31st December, 2019 received from M/s. Bigshare Services Pvt. Ltd., Registrar and Share Transfer Agent of our company.
09-01-2020
Bigul

Indo Us Bio-Tech Ltd - 541304 - Announcement Under Regulation 30- Intimation For Award Winning Of Being One Of The Top Performers In SME Segment Of BSE For The Financial Year 2018-19.

 Indo Us Bio-Teach Limited has informed BSE that the Company has been awarded by BSE Limited for being one of the top performers in SME Segment of BSE. The award has been received by Mr. Jagdish Ajudia, Managing Director of the Company from BSE Officials at Diwali Muhurat Trading function and Felicitation of Top Volume Performers Programme of BSE held on October 27, 2019, at Mumbai. The Board of Directors and Top Management express sincere thanks for the same.
16-11-2019
Bigul

Indo Us Bio-Tech Ltd - 541304 - Announcement under Regulation 30 (LODR)-Resignation of Director

 We would like to inform the exchange that Mr. ANILKUMAR KANJIBHAI PATEL (DIN: 00156538), and Mr. GORDHANBHAI KARSHANBHAI GANGANI (DIN: 08015173) both Non- Executive and Independent Directors of the Company have, vide their letters dated 14th November, 2019, tendered their resignation as Director of the Company from the said position. The Board, at their Meeting held on 14th November, 2019 has accepted the resignation of both the directors with effect from same date. You are kindly requested to take the aforesaid on your records.
14-11-2019
Bigul

Indo Us Bio-Tech Ltd - 541304 - Announcement under Regulation 30 (LODR)-Change in Directorate

 Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 this is inform you that the Board of Directors of the Company has appointed the following Directors on the Board of the Company by passing resolution on 14.11.2019 pursuant to the provisions of the Companies Act, 2013 and SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015:- Appointment of Ms. Nidhi Ajudia as an Additional Director (Non Executive Independent) Appointment of Mr. Samarth Patel as an Additional Director (Non Executive Independent)
14-11-2019
Bigul

Indo Us Bio-Tech Ltd - 541304 - Results-Financial Results For The Quarter And Half Year Ended On 30.09.2019

 With regard to captioned subject, the Board of Directors at its meeting held on today i.e. Thursday, 14th November, 2019 commenced at 04:00 P.M. and concluded at 04:45 P.M. has considered and approved the unaudited financial results for the half year ended on 30th September, 2019. The said financial results were accompanied by the limited review report given by the Statutory Auditor of the Company, Statement of Assets and Liabilities and income and Expense Statement.
14-11-2019
Bigul

Indo Us Bio-Tech Ltd - 541304 - Board Meeting Intimation for Holding Of Board Of Directors Meeting To Consider And Take On Record The Unaudited Financial Results For The Quarter And Half Year Ended On 30Th September, 2019

 Indo Us Bio-Tech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2019 ,inter alia, to consider and approve Unaudited Financial Results for the Quarter and Half year ended on 30th September, 2019.
07-11-2019
Bigul

Indo Us Bio-Tech Ltd - 541304 - Compliances-Certificate From Practicing Company Secretary Under Regulation 40(9) Of SEBI (Listing Obligations And Disclosure Requirements)Regulations, 2015 For Half Year Ended On 30Th September, 2019

 Please find enclosed a Certificate dated October 19, 2019 Pursuant to Regulation 40(9) of the Securities & Exchange Board of India (Listing Obligations & Disclosure Requirements) Regulations 2015, kindly find an enclosed copy of the Certificate from Practicing Company Secretary for the half year ended on 30th September, 2019.
19-10-2019
Next Page
Close

Let's Open Free Demat Account